Evidence map›Paper›PMID 34382945›Full record

ArticleAging2021

Endothelium-specific deletion of amyloid-β precursor protein exacerbates endothelial dysfunction induced by aging.

Livius V d'Uscio, Zvonimir S Katusic

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. How to measure and model cardiovascular aging.Cardiovascular research · 2025
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Livius V d'UscioDepartments of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN 55902, USA.
Zvonimir S KatusicDepartments of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN 55902, USA.
WinnMed · US

Funding

Endothelial function of amyloid precursor proteinR01HL131515 · NHLBI · MAYO CLINIC ROCHESTER · PI KATUSIC, ZVONIMIR S · 2016 to 2019
$2.1M
NHLBI NIH HHS R01 HL131515
6 · The paper itself

Abstract

The physiological function of amyloid precursor protein (APP) in the control of endothelial function during aging is unclear. Aortas of young (4-6 months old) and aged (23-26 months old) wild-type (WT) and endothelium-specific APP-deficient (eAPP

Indexed as

AgingAmyloid beta-Protein PrecursorAnimalsAorta, ThoracicCyclooxygenase 2Cyclooxygenase InhibitorsEndothelium, VascularIndomethacinMaleMiceMice, KnockoutNitric Oxide Synthase Type IIIProstaglandinsVasoconstrictionVasodilationAmyloid beta-Protein PrecursorAPP protein, mouseCyclooxygenase 2Cyclooxygenase InhibitorsIndomethacinNitric Oxide Synthase Type IIIProstaglandinsagingamyloid precursor proteinendothelial nitric oxide synthaseendotheliumprostaglandins

Identifiers

PMID34382945
PMCPMC8386539
OpenAlexW3189901876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.